Ohio Medicaid limits GLP-1 coverage to type 2 diabetes; the obesity indication isn't a covered benefit. The coverage that exists is gated by prior authorization.
Ohio Medicaid covers GLP-1 drugs such as Ozempic, Mounjaro, Trulicity, Rybelsus and Victoza for type 2 diabetes with prior authorization. The prior authorization typically looks for a documented type 2 diabetes diagnosis and, often, a trial of a first-line oral drug such as metformin.
The same molecules can be covered under a different FDA-approved use even though weight loss is excluded — for example Wegovy for cardiovascular risk in people with established heart disease, or Zepbound for obstructive sleep apnea, and the diabetes brands (Ozempic, Mounjaro) for type 2 diabetes.
Tell us your plan, drug and reason, and see whether you're likely covered — plus exactly what to document or how to appeal.
Check my coverageYes, for type 2 diabetes with prior authorization. Ohio Medicaid covers GLP-1s like Ozempic for diabetes when the clinical criteria are met. Ozempic is not covered for weight loss.
No. Ohio Medicaid does not cover anti-obesity GLP-1s like Wegovy or Zepbound for weight loss; coverage is limited to type 2 diabetes.
Sometimes. FDA-approved non-weight-loss uses may be covered — for example Wegovy for cardiovascular risk with established heart disease, or Zepbound for obstructive sleep apnea.
Generally yes, or another oral diabetes drug. Most Medicaid diabetes rules expect a trial of a first-line oral medication such as metformin before a GLP-1 is approved.
Related: Weight-loss coverage — the full guide · Does Medicare cover Wegovy? · California (Medi-Cal) · Texas · Florida · New York · Illinois